N-乙酰氨基葡萄糖转移酶及相关显像剂摄取研究

梁杰; 陈跃; 匡安仁

梁杰 , 陈跃 , 匡安仁

文章导航 > 国际放射医学核医学杂志 > 2007, 31 > 5: (267-270)

引用本文:

Citation:

N-乙酰氨基葡萄糖转移酶及相关显像剂摄取研究

1. 646000 四川, 四川省泸州医学院附属医院核医学科;
2. 610041 成都, 四川大学华西医院核医学科
基金项目:
四川省科技厅应用基础资助项目(2006J13-032)
中图分类号: Q555⁺.3;R817.4

Study on N-acetylglucosaminyl transferase and the uptake of the correlated imaging agent

1. Department of Nuclear Medicine, Affiliated Hospital of Luzhou Medical College, Luzhou Sichuan 646000, China;
2. Department of Nuclear Medicine, West China Hospital, Sichuan University, Chengdu Sichuan 610041, China
CLC number: Q555⁺.3;R817.4

摘要: N-乙酰氨基葡萄糖转移酶(GnT)通过影响糖链的改变而间接关系到肿瘤的发展与癌症患者的预后.研究肿瘤组织的糖基转移酶变化,有助于了解肿瘤的生物学行为机制.随着新型肿瘤葡萄糖类似物显像剂的发展,显像机制的研究进一步明确,为肿瘤的无创伤性诊治提供新途径.
- N-乙酰氨基葡萄糖转移酶类 /
- 糖基转移酶类 /
- 肿瘤
Abstract: N-acetylglueosaminyl transferase(GnT) is related to the development of tumor and the cancer patients' prognosis by effecting the change of glucose's chain. Study on the transform of glycosyhransferase is benefit to the comprehension of the mechanism of biological behavior. The noninvasive diagnostic and treating methods of tumor will be provided along with the development of new imaging agent of tumor glucose analogue and its mechanism defined clearly.
- N-acetylglucnsaminyl transferase /
- Glycosyltransferases /
- Neoplasms
本作品遵循Signature-Non-Commercial Use 4.0 International (CC BY-NC 4.0)协议

[1]	Comer FI, Hart GW. O-Glycosylation of nuclear and cytosolic proteins:dynamic interplay' between O-GlcNAc and O-Phosphate. J Biol Chem, 2000, 275(38):29179-29182.
[2]	Murata K, Miyoshi E, Ihara S, et al. Attachment of human colon cancer cells to vascular endothelium is enhanced by N-Acetylglucosaminyltransferase Ⅴ. Oneology, 2004, 66(6):492-501.
[3]	陈惠黎.糖复合物的结构和功能.上海:上海医科大学出版社,1997.106-108.
[4]	Nishikawa A, Gu J, Fujii S, et al. Determination of N-acetylglucosaminyltransferase Ⅲ, Ⅳ and Ⅴ in normal and hepatoma tissues of rats. Biochim Biophys Acta, 1990, 1035(3):313-318.
[5]	Yao M, Zhou DP, Jiang SM, et al. Elevated activity of N-acetylglueosaminytransferase Ⅴ in human hepatocellular carcinoma. J Caneer Res Clin Oncol, 1998, 124(1):27-30.
[6]	陈海霞,耿美玉,管华诗.癌相关N-乙酰氨基葡萄糖转移酶研究进展.中国生物工程杂志,2004,24(2):22-25.
[7]	Dwek MV, Ross HA, l,eathem AJ. Pmteome and glycosylation mapping identifies post-translational modifications associated with aggressive breast cancer. Proteomics, 2001, 1(6):756-762.
[8]	徐莺莺,陆祎,张毅,等.肝癌细胞N-乙酰氨基葡萄糖基转移酶V表达受阻与内质网应激之间的关系.中国癌症杂志,2005,15(2):130-134.
[9]	Shuda M, Kondoh N, lmazeki N, et al. Activation of ATF6, XBP1 and GRP78 in human hepatoecllular carcinoma:a possible involvement of the ER stress pathway in hepatocarcinogenesis. J Hepatol, 2003, 38(5):605-614.
[10]	Chakraborty AK, Pawelek JM. GnT-V, macrophage and cancer metastasis a common link. Clin Exp Metastasis, 2003, 20(4):365-373.
[11]	Guo HB, Lee U, Kamar M, et al. Aberrant N-glycosylation of beta 1 integrin causes reduced alpha5 beta 1 integrin clustering and stimulates cell migration. Cancer Res, 2002, 62(23):6837-6845.
[12]	Yanagi M, Aoyagi Y, Suda T, et al. N-Aeetylglucosaminyltransferase Ⅴ as a possible aid for the evaluation of tumor invasiveness in patients with hepatocellular carcinoma. J Gastroenterol Hepatol, 2001, 16(11):1282-1289.
[13]	Guo HB, Liu F, Chen HL. Inereased susceptibility to apoptosis of human hepatoeareinoma cells transfected with antisense Nacetylglucosaminyltransterase Ⅴ cDNA. Biochem Biophys Res Commun, 1999, 264(2):509-517.
[14]	Murata K, Miyoshi E, Kameyama M, et al. Expression of N-acetylglucosaminyltransferase Ⅴ in colorectal cancer correlates with metastasis and poorprognosis. Clin Cancer Res,2000, 6(5):1772-1777.
[15]	Guo P, Zhang Y, Zhao JH, et al. Regulation on the expression and N-glycosylation of integrins by N-acetylglucosaminyltransferase Ⅴ. Biochem Biophys Res Commun, 2003, 310(2):619-626.
[16]	Handerson T, Pawelek JM. Beta 1,6-branched oligosaccharides and coarse vesicles:a common, pervasive phenotype in melanoma and other human cancers. Cancer Res, 2003, 63(17):5363-5369.
[17]	Ekunl A, Miyoshi E, Ko JH, et al. A glycomic approach to hepatic tumors in N-acetyglucosaminyltransferase Ⅲ (GnT-Ⅲ) transgenie mice induced by diethylnitrosamine (DEN):identification of haptoglobin as a target molecule of GoT-Ⅲ. Free Radic Res, 2002, 36(8):827-833.
[18]	Yang DJ, Azhdarinia A, Kim EE. Tumor specific imaging using ^99mTc and 68Ga labelled radiopharmaceuticals. Current medical imaging reviews, 2005, 1(1):25-34.
[19]	Yang DJ, Kim CG, Schechter NR, et al. Imaging with ^99mTc ECDG targeted at the multifunctional glucose transport system:feasibility study with rodents. Radiology, 2003, 226(2):465-473.
[20]	Yang D, Yukihiro M, Yu DF, et al. Assessment of therapeutic tumor response using ^99mTc-ethylenedicysteine-glucosamine. Cancer Biother Radiopharm, 2004, 19(4):443-456.
[21]	Chen Y, Huang ZW, He L, et al. Synthesis anti characterization of ^99mTc-DTPA-DG for tumor detection. Eur J Nucl Med Mol hnaging,2005, 32(9):S270.
[22]	Chen Y, HuangZW, He L, et al. Synthesis and evaluation ofa tech-netium-99m-labelled diethylenetriaminepentaacetate-deoxyglucose complex ([^99mTc]-DTPA-DG) as a potential imaging modality for tumors. Appl Radiat Isot, 2006, 64(3):342-347.

[1]	徐金苹 , 袁德晓 , 张江虹 , 邵春林 . 辐射诱导的外泌体在肿瘤细胞侵袭转移中的作用. 国际放射医学核医学杂志, 2015, 39(2): 144-148. doi: 10.3760/cma.j.issn.1673-4114.2015.02.009
[2]	司宏伟 , 徐慧琴 , 岳峤 , 耿建华 , 陈盛祖 . 肿瘤组织乏氧与葡萄糖代谢. 国际放射医学核医学杂志, 2009, 33(4): 200-203. doi: 10.3760/cma.j.issn.1673-4114.2009.04.003
[3]	孙琳 , 高再荣 , 张永学 . ¹⁸F-氟代脱氧葡萄糖PET-CT用于恶性肿瘤治疗疗效评估与监测. 国际放射医学核医学杂志, 2006, 30(6): 328-331.
[4]	吕慧清 , 张中民 , 吕仲虹 . ¹⁸F-氟代脱氧葡萄糖PET在恶性肿瘤适形放射治疗中的价值. 国际放射医学核医学杂志, 2006, 30(6): 335-337.
[5]	张敏 , 李彪 , 张一帆 . 组蛋白去乙酰化酶抑制剂在抗肿瘤应用中的进展. 国际放射医学核医学杂志, 2007, 31(5): 270-273.
[6]	刘晓秋 , 李雨民 . 高密度50Hz磁场暴露增加次黄嘌呤-鸟嘌呤磷酸核糖基转移酶基因突变. 国际放射医学核医学杂志, 1997, 21(2): 94-94.
[7]	宋少莉 , 黄钢 . ¹⁸F-氟脱氧葡萄糖PET监测实体瘤放化疗疗效的应用进展. 国际放射医学核医学杂志, 2007, 31(5): 284-288.
[8]	王浩 , 周则卫 , 周晓靓 . N-（5-硝基吲唑-3-甲酰）酪氨酸钠的制备、乏氧增敏与体内分布研究. 国际放射医学核医学杂志, 2015, 39(3): 235-238. doi: 10.3760/cma.j.issn.1673-4114.2015.03.010
[9]	尹其华 . ¹⁶⁶Ho-、¹⁵³Sm-聚氨基葡糖:理想的内照射治疗药物. 国际放射医学核医学杂志, 2003, 27(6): 245-247.
[10]	刘光伟 , 龚守良 . siRNA与肿瘤放射治疗. 国际放射医学核医学杂志, 2004, 28(4): 169-172.